The global surgical dressing market is expected to reach USD 5.2 billion by 2025 with a CAGR of 5.2% from 2018 to 2025 according to a new report by Polaris Market Research. This traction in the market is due to the increase in different types of surgeries such as organ transplant surgeries, cardiovascular surgeries, and other surgeries.
Along with the increased surgeries, the increasing implementation of the Ambulatory Surgery Centers (ASCs) in both developed and developing nations have benefitted this market. These ASCs carry out different surgeries such as urology, orthopedics, reconstructive and gastro intestinal related surgeries, which demand surgical dressing products.
The major driving factor for this market is the increase in the cardiovascular diseases due to changing lifestyles. It is estimated that by 2020 the cardiovascular diseases (CVDs) would account majorly for health issues of people in the developing countries such as India, China, Malaysia, in the Asia-Pacific region. Similarly, in developed countries such as US and other major countries from Europe, majority of the people suffer from CVDs. This surge is pushing the market for Surgical Dressings.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/surgical-dressing-market/request-for-sample
The another key driver for this market is the increased disease burden of Cardiovascular Diseases (CVD) and the resultant surgeries for the treatment or management of the disease. It was estimated by the American Heart Association (AHA) that 92.1 million adults in the U.S. would suffer from at least one type of CVD by 2017.
The surgical dressing market is segmented on the basis of product type, application and end-user. On the basis of product type, the global surgical dressing market is segmented into Primary and secondary dressings, among this, primary dressing market is estimated to hold the largest market share in 2017.
On the basis of application, there are various applications for surgical dressings and the application type segment is further broken down into Diabetes based surgeries, Ulcers Surgeries, Burns Surgeries, Transplant Surgeries, Cardiovascular Diseases (CVD) based surgeries, and others. The CVD based surgeries is the fastest growing segment with a growth rate followed by the transplant surgeries and diabetes related surgeries.
Surgical dressings market is further categorized into by end-user which include hospitals, home healthcare, ambulatory centers, specialty clinics and others. It is estimated that the hospital segment has the largest market share during the forecast period, however, the ambulatory centers is growing with the highest growth rate. The major reason for this traction is due to the increasing adoption of ambulatory centers in the developed and developing regions.
Request For Discount Price: https://www.polarismarketresearch.com/industry-analysis/surgical-dressing-market/request-for-discount-pricing
The major players in the surgical dressing market include companies such as 3M, Smith & Nephew, Advancis Medical, Medline Industries, BSN Medical, ConvaTec, Acelity, Medtronic, Alliqua Biomedical, Coloplast, and Mölnlycke Health Care AB.
New York, NY 25 Feb 2021 : The global surgical dressing market is expected to reach USD 5.2 billion by 2025 with a CAGR of 5.2% from 2018 to 2025 according to a new report by Polaris Market Research.
This traction in the market is due to the increase in different types of surgeries such as organ transplant surgeries, cardiovascular surgeries, and other surgeries.
Along with the increased surgeries, the increasing implementation of the Ambulatory Surgery Centers (ASCs) in both developed and developing nations have benefitted this market.
These ASCs carry out different surgeries such as urology, orthopedics, reconstructive and gastro intestinal related surgeries, which demand surgical dressing products.
The major driving factor for this market is the increase in the cardiovascular diseases due to changing lifestyles.
It is estimated that by 2020 the cardiovascular diseases (CVDs) would account majorly for health issues of people in the developing countries such as India, China, Malaysia, in the Asia-Pacific region.
The global surgical dressing market is expected to reach USD 5.2 billion by 2025 with a CAGR of 5.2% from 2018 to 2025 according to a new report by Polaris Market Research.
Request For Sample Copy & All Related Graphs & Charts @ https://www.polarismarketresearch.com/industry-analysis/surgical-dressing-market/request-for-sample Along with the increased surgeries, the increasing implementation of the Ambulatory Surgery Centers (ASCs) in both developed and developing nations have benefitted this market.
These ASCs carry out different surgeries such as urology, orthopedics, reconstructive and gastro intestinal related surgeries, which demand surgical dressing products.
The major driving factor for this market is the increase in the cardiovascular diseases due to changing lifestyles.
It is estimated that by 2020 the cardiovascular diseases (CVDs) would account majorly for health issues of people in the developing countries such as India, China, Malaysia, in the Asia-Pacific region.
Similarly, in developed countries such as US and other major countries from Europe, majority of the people suffer from CVDs.
The global coronary stents market size is expected to reach USD 11.3 billion by 2027, expanding at a CAGR of 4.7%, according to a new report by Radiant Insights, Inc. Increasing adoption of minimally invasive surgeries and percutaneous coronary intervention (PIC) procedures is expected to drive the market for coronary stents in the coming years.
Moreover, increasing geriatric population is considered as a high impact rendering driver for the growth of this industry over the forecast period.
Development of biodegradable and polymer free DES in order to increase patient compliance is expected to drive the market over the coming years.
Download Free Sample Report @ https://www.radiantinsights.com/research/coronary-stents-market/request-sample The coronary stent market is driven by reimbursement coverage provided by the general public Center for Medicare and Medicaid Services (CMS) and private payers.
The coverage is availed under national coverage determination for carotid artery stenting, including products and service provider.
From January 2020, Centers for Medicare & Medicaid Services (CMS) proposed reimbursement for some angioplasty and stenting procedures performed in ambulatory surgical center (ASC), which is expected to boost market revenue over the forecast period.
According to research report the global MIS Instruments Market is expected to grow from USD 20.1 billion in 2019 to USD 32.7 billion by 2025, at a CAGR of 8.5% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 The major companies in the global minimally invasive surgical instruments market include Medtronic plc (Ireland), Johnson & Johnson (US), Stryker Corporation (US), B. Braun Melsungen AG (Germany), Smith & Nephew plc (US), Boston Scientific Corporation (US), and CONMED Corporation (US).
The advantages of minimally invasive surgeries over traditional open surgeries and the increasing number of minimally invasive surgical procedures across the globe are the key factors driving market growth.
By type of surgery, the cardiothoracic surgery segment accounted for the largest share of the global MIS instruments market in 2018.
The cardiothoracic surgery segment accounted for the largest share of the global MIS devices market in 2018.
The large share of this segment can be attributed to the rising prevalence of cardiac diseases, growing awareness about the benefits of early detection of cardiovascular complications, the growing number of coronary and percutaneous cardiology interventions, and increasing adoption of MIS instruments owing to their convenience and better results as compared to other techniques.
